$ENOV
Enovis CORP

2021 Q2 Form 10-Q Financial Statement

#000142080021000016 Filed on April 29, 2021

View on sec.gov

Income Statement

Concept 2021 Q2 2020 Q2
Revenue $879.2M $816.4M
YoY Change 7.7% -10.16%
Cost Of Revenue $508.1M $468.1M
YoY Change 8.54% -12.1%
Gross Profit $371.1M $348.2M
YoY Change 6.57% -7.4%
Gross Profit Margin 42.21% 42.65%
Selling, General & Admin $305.7M $292.2M
YoY Change 4.63% -5.11%
% of Gross Profit 82.39% 83.91%
Research & Development $19.90M $18.50M
YoY Change 7.57% -43.25%
% of Gross Profit 5.36% 5.31%
Depreciation & Amortization $62.79M $58.34M
YoY Change 7.63%
% of Gross Profit 16.92% 16.75%
Operating Expenses $325.6M $310.7M
YoY Change 4.8% -8.76%
Operating Profit $61.31M $46.84M
YoY Change 30.89% 12.77%
Interest Expense $25.66M $24.80M
YoY Change 3.48% -25.25%
% of Operating Profit 41.85% 52.94%
Other Income/Expense, Net
YoY Change
Pretax Income $35.65M $22.04M
YoY Change 61.73% 163.55%
Income Tax $7.900M $13.20M
% Of Pretax Income 22.16% 59.89%
Net Earnings $20.24M $5.508M
YoY Change 267.47% -101.17%
Net Earnings / Revenue 2.3% 0.67%
Basic Earnings Per Share $0.41 $0.03
Diluted Earnings Per Share $0.40 $0.03
COMMON SHARES
Basic Shares Outstanding 46.53M shares 136.6M shares
Diluted Shares Outstanding 47.26M shares 141.5M shares

Balance Sheet

Concept 2021 Q2 2020 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $763.7M
YoY Change
Cash & Equivalents $763.7M $365.6M
Short-Term Investments
Other Short-Term Assets $79.11M $154.9M
YoY Change -48.94% -9.73%
Inventory $606.2M $561.7M
Prepaid Expenses $75.21M
Receivables $553.8M $499.4M
Other Receivables $0.00
Total Short-Term Assets $2.078B $1.582B
YoY Change 31.38% -56.51%
LONG-TERM ASSETS
Property, Plant & Equipment $479.2M $468.2M
YoY Change 2.35% -4.24%
Goodwill $3.332B $3.191B
YoY Change 4.39% 13.08%
Intangibles $1.653B $1.648B
YoY Change 0.28% -28.78%
Long-Term Investments
YoY Change
Other Assets $354.3M $392.1M
YoY Change -9.64% -18.87%
Total Long-Term Assets $5.989B $5.874B
YoY Change 1.95% -6.21%
TOTAL ASSETS
Total Short-Term Assets $2.078B $1.582B
Total Long-Term Assets $5.989B $5.874B
Total Assets $8.067B $7.456B
YoY Change 8.2% -24.69%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $406.7M $368.0M
YoY Change 10.53% -7.96%
Accrued Expenses $424.3M $424.2M
YoY Change 0.02% -5.43%
Deferred Revenue
YoY Change
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due $727.4M $26.89M
YoY Change 2605.48% -31.98%
Total Short-Term Liabilities $1.558B $819.1M
YoY Change 90.26% -48.76%
LONG-TERM LIABILITIES
Long-Term Debt $1.482B $2.513B
YoY Change -41.03% -38.38%
Other Long-Term Liabilities $597.8M $650.1M
YoY Change -8.05% -23.22%
Total Long-Term Liabilities $2.080B $3.163B
YoY Change -34.25% -35.77%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.558B $819.1M
Total Long-Term Liabilities $2.080B $3.163B
Total Liabilities $3.776B $4.118B
YoY Change -8.31% -38.01%
SHAREHOLDERS EQUITY
Retained Earnings $536.4M $479.2M
YoY Change 11.94% -1.38%
Common Stock $135.0K $118.0K
YoY Change 14.41% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $4.247B $3.291B
YoY Change
Total Liabilities & Shareholders Equity $8.067B $7.456B
YoY Change 8.2% -24.69%

Cashflow Statement

Concept 2021 Q2 2020 Q2
OPERATING ACTIVITIES
Net Income $20.24M $5.508M
YoY Change 267.47% -101.17%
Depreciation, Depletion And Amortization $62.79M $58.34M
YoY Change 7.63%
Cash From Operating Activities $84.38M $56.23M
YoY Change 50.07%
INVESTING ACTIVITIES
Capital Expenditures $24.54M $31.11M
YoY Change -21.14%
Acquisitions $103.5M $7.830M
YoY Change 1221.52%
Other Investing Activities -$103.5M
YoY Change
Cash From Investing Activities -$128.0M -$37.26M
YoY Change 243.61%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net $0.00
YoY Change
Cash From Financing Activities $707.7M $245.1M
YoY Change 188.68%
NET CHANGE
Cash From Operating Activities $84.38M $56.23M
Cash From Investing Activities -$128.0M -$37.26M
Cash From Financing Activities $707.7M $245.1M
Net Change In Cash $662.6M $256.0M
YoY Change 158.85%
FREE CASH FLOW
Cash From Operating Activities $84.38M $56.23M
Capital Expenditures $24.54M $31.11M
Free Cash Flow $59.85M $25.12M
YoY Change 138.27%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q2 dei Amendment Flag
AmendmentFlag
false
CY2021Q2 dei Entity Registrant Name
EntityRegistrantName
Colfax CORP
CY2021Q2 dei Entity Central Index Key
EntityCentralIndexKey
0001420800
CY2021Q2 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2021Q2 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2021Q2 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
CY2021Q2 dei Document Type
DocumentType
10-Q
CY2021Q2 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2021Q2 dei Document Period End Date
DocumentPeriodEndDate
2021-04-02
CY2021Q2 dei Document Transition Report
DocumentTransitionReport
false
CY2021Q2 dei Entity File Number
EntityFileNumber
001-34045
CY2021Q2 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2021Q2 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
54-1887631
CY2021Q2 dei Entity Address Address Line1
EntityAddressAddressLine1
420 National Business Parkway,
CY2021Q2 dei Entity Address Address Line2
EntityAddressAddressLine2
5th Floor
CY2021Q2 dei Entity Address City Or Town
EntityAddressCityOrTown
Annapolis Junction,
CY2021Q2 dei Entity Address State Or Province
EntityAddressStateOrProvince
MD
CY2021Q2 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
20701
CY2021Q2 dei City Area Code
CityAreaCode
(301)
CY2021Q2 dei Local Phone Number
LocalPhoneNumber
323-9000
CY2021Q2 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2021Q2 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2021Q2 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2021Q2 dei Entity Small Business
EntitySmallBusiness
false
CY2021Q2 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2021Q2 dei Entity Shell Company
EntityShellCompany
false
CY2021Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
135597331 shares
CY2021Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
879211000 USD
CY2020Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
816356000 USD
CY2021Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
508134000 USD
CY2020Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
468142000 USD
CY2021Q2 us-gaap Gross Profit
GrossProfit
371077000 USD
CY2020Q2 us-gaap Gross Profit
GrossProfit
348214000 USD
CY2021Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
305724000 USD
CY2020Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
292197000 USD
CY2021Q2 us-gaap Restructuring Charges
RestructuringCharges
4046000 USD
CY2020Q2 us-gaap Restructuring Charges
RestructuringCharges
9180000 USD
CY2021Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
61307000 USD
CY2020Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
46837000 USD
CY2021Q2 us-gaap Interest Expense
InterestExpense
25660000 USD
CY2020Q2 us-gaap Interest Expense
InterestExpense
24796000 USD
CY2021Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
35647000 USD
CY2020Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
22041000 USD
CY2021Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
7917000 USD
CY2020Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
13173000 USD
CY2021Q2 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
27730000 USD
CY2020Q2 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
8868000 USD
CY2021Q2 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
-7490000 USD
CY2020Q2 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
-3360000 USD
CY2021Q2 us-gaap Profit Loss
ProfitLoss
20240000 USD
CY2020Q2 us-gaap Profit Loss
ProfitLoss
5508000 USD
CY2021Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
1166000 USD
CY2020Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
1027000 USD
CY2021Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
19074000 USD
CY2020Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
4481000 USD
CY2021Q2 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.19
CY2020Q2 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.06
CY2021Q2 us-gaap Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Basic Share
DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare
-0.05
CY2020Q2 us-gaap Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Basic Share
DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare
-0.02
CY2021Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.14
CY2020Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.03
CY2021Q2 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0.19
CY2020Q2 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0.06
CY2021Q2 us-gaap Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Diluted Share
DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare
-0.05
CY2020Q2 us-gaap Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Diluted Share
DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare
-0.02
CY2021Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.13
CY2020Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.03
CY2021Q2 us-gaap Profit Loss
ProfitLoss
20240000 USD
CY2020Q2 us-gaap Profit Loss
ProfitLoss
5508000 USD
CY2020Q2 us-gaap Profit Loss
ProfitLoss
5508000 USD
CY2021Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax
OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
2280000 USD
CY2020Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax
OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
519000 USD
CY2021Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-53181000 USD
CY2020Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-172792000 USD
CY2021Q2 us-gaap Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Tax
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodTax
4243000 USD
CY2020Q2 us-gaap Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Tax
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodTax
3873000 USD
CY2021Q2 us-gaap Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax
12381000 USD
CY2020Q2 us-gaap Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax
11036000 USD
CY2021Q2 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci Pension And Other Postretirement Benefit Plans For Net Gain Loss Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax
317000 USD
CY2020Q2 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci Pension And Other Postretirement Benefit Plans For Net Gain Loss Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax
252000 USD
CY2021Q2 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci Pension And Other Postretirement Benefit Plans For Net Gain Loss Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax
-1055000 USD
CY2020Q2 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci Pension And Other Postretirement Benefit Plans For Net Gain Loss Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax
-866000 USD
CY2021Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-39745000 USD
CY2020Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-160890000 USD
CY2021Q2 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-19505000 USD
CY2020Q2 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-155382000 USD
CY2021Q2 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
1042000 USD
CY2020Q2 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-1567000 USD
CY2021Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-20547000 USD
CY2020Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-153815000 USD
CY2021Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
763653000 USD
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
97068000 USD
CY2021Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
35560000 USD
CY2020Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
37666000 USD
CY2021Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
553785000 USD
CY2020Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
517006000 USD
CY2021Q2 us-gaap Inventory Net
InventoryNet
606208000 USD
CY2020Q4 us-gaap Inventory Net
InventoryNet
564822000 USD
CY2021Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
75205000 USD
CY2020Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
69515000 USD
CY2021Q2 us-gaap Other Assets Current
OtherAssetsCurrent
79114000 USD
CY2020Q4 us-gaap Other Assets Current
OtherAssetsCurrent
113418000 USD
CY2021Q2 us-gaap Assets Current
AssetsCurrent
2077965000 USD
CY2020Q4 us-gaap Assets Current
AssetsCurrent
1361829000 USD
CY2021Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
479240000 USD
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
486960000 USD
CY2021Q2 us-gaap Goodwill
Goodwill
3331531000 USD
CY2020Q4 us-gaap Goodwill
Goodwill
3314541000 USD
CY2021Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1652957000 USD
CY2020Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1663446000 USD
CY2021Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
170620000 USD
CY2020Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
173942000 USD
CY2021Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
354301000 USD
CY2020Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
350831000 USD
CY2021Q2 us-gaap Assets
Assets
8066614000 USD
CY2020Q4 us-gaap Assets
Assets
7351549000 USD
CY2021Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
727369000 USD
CY2020Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
27074000 USD
CY2021Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
406744000 USD
CY2020Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
330251000 USD
CY2021Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
424298000 USD
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
454333000 USD
CY2021Q2 us-gaap Liabilities Current
LiabilitiesCurrent
1558411000 USD
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
811658000 USD
CY2021Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1481997000 USD
CY2020Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
2204169000 USD
CY2021Q2 cfx Operating Lease Liability Present Value Noncurrent
OperatingLeaseLiabilityPresentValueNoncurrent
137329000 USD
CY2020Q4 cfx Operating Lease Liability Present Value Noncurrent
OperatingLeaseLiabilityPresentValueNoncurrent
139230000 USD
CY2021Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
597808000 USD
CY2020Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
608618000 USD
CY2021Q2 us-gaap Liabilities
Liabilities
3775545000 USD
CY2020Q4 us-gaap Liabilities
Liabilities
3763675000 USD
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
400000000 shares
CY2021Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
400000000 shares
CY2021Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
135597331 shares
CY2021Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
135597331 shares
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
118496687 shares
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
118496687 shares
CY2021Q2 us-gaap Common Stock Value
CommonStockValue
135000 USD
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
118000 USD
CY2021Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
4201745000 USD
CY2020Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
3478008000 USD
CY2021Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
536441000 USD
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
517367000 USD
CY2021Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-491727000 USD
CY2020Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-452106000 USD
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
4246594000 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
3543387000 USD
CY2021Q2 us-gaap Minority Interest
MinorityInterest
44475000 USD
CY2020Q4 us-gaap Minority Interest
MinorityInterest
44487000 USD
CY2021Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
4291069000 USD
CY2020Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
3587874000 USD
CY2021Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
8066614000 USD
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
7351549000 USD
CY2020Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
3587874000 USD
CY2021Q2 us-gaap Profit Loss
ProfitLoss
20240000 USD
CY2021Q2 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
1054000 USD
CY2021Q2 us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
6840000 USD
CY2021Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-39745000 USD
CY2021Q2 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
971000 USD
CY2021Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
711321000 USD
CY2021Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
13404000 USD
CY2020Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
8344000 USD
CY2020Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
3337764000 USD
CY2021Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
4291069000 USD
CY2019Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
3489628000 USD
CY2020Q2 us-gaap Profit Loss
ProfitLoss
5508000 USD
CY2020Q2 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
8000 USD
CY2020Q2 us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
4644000 USD
CY2020Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-160890000 USD
CY2021Q2 us-gaap Profit Loss
ProfitLoss
20240000 USD
CY2020Q2 us-gaap Profit Loss
ProfitLoss
5508000 USD
CY2020Q2 us-gaap Profit Loss
ProfitLoss
5508000 USD
CY2021Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
62785000 USD
CY2020Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
58336000 USD
CY2021Q2 us-gaap Share Based Compensation
ShareBasedCompensation
7807000 USD
CY2020Q2 us-gaap Share Based Compensation
ShareBasedCompensation
6124000 USD
CY2021Q2 cfx Noncashinterestexpense
Noncashinterestexpense
1537000 USD
CY2020Q2 cfx Noncashinterestexpense
Noncashinterestexpense
1311000 USD
CY2021Q2 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-3614000 USD
CY2020Q2 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-567000 USD
CY2021Q2 us-gaap Gain Loss On Sale Of Properties
GainLossOnSaleOfProperties
-257000 USD
CY2020Q2 us-gaap Gain Loss On Sale Of Properties
GainLossOnSaleOfProperties
-976000 USD
CY2021Q2 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
39950000 USD
CY2020Q2 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-29445000 USD
CY2021Q2 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
32743000 USD
CY2020Q2 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
16431000 USD
CY2021Q2 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
83442000 USD
CY2020Q2 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
30592000 USD
CY2021Q2 us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
15379000 USD
CY2020Q2 us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
59065000 USD
CY2021Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
84382000 USD
CY2020Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
56229000 USD
CY2021Q2 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
24537000 USD
CY2020Q2 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
31113000 USD
CY2021Q2 us-gaap Proceeds From Sale Of Buildings
ProceedsFromSaleOfBuildings
0 USD
CY2020Q2 us-gaap Proceeds From Sale Of Buildings
ProceedsFromSaleOfBuildings
1688000 USD
CY2021Q2 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
103475000 USD
CY2020Q2 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
7830000 USD
CY2021Q2 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-128012000 USD
CY2020Q2 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-37255000 USD
CY2021Q2 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
179367000 USD
CY2020Q2 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
608673000 USD
CY2021Q2 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
185643000 USD
CY2020Q2 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
364403000 USD
CY2021Q2 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
716632000 USD
CY2020Q2 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
2220000 USD
CY2021Q2 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-2704000 USD
CY2020Q2 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-1353000 USD
CY2021Q2 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
707652000 USD
CY2020Q2 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
245137000 USD
CY2021Q2 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-1438000 USD
CY2020Q2 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-8139000 USD
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
662584000 USD
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
255972000 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
101069000 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
109632000 USD
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
763653000 USD
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
365604000 USD
CY2021Q2 us-gaap Use Of Estimates
UseOfEstimates
The Company makes certain estimates and assumptions in preparing its Condensed Consolidated Financial Statements in accordance with GAAP. These estimates and assumptions affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities as of the date of the Condensed Consolidated Financial Statements and the reported amounts of revenues and expenses for the periods presented. Actual results may differ from those estimates.In the normal course of business, the Company incurs research and development costs related to new product development which are expensed as incurred and included in Selling, general and administrative expenses on the Company’s Condensed Consolidated Statements of Operations. Research and development costs were $19.9 million during the three months ended April 2, 2021, and $18.5 million during the three months ended April 3, 2020.
CY2021Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
19900000 USD
CY2020Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
18500000 USD
CY2021Q2 cfx Disposal Group Including Discontinued Operations Asbestos Related Costs Net Of Tax
DisposalGroupIncludingDiscontinuedOperationsAsbestosRelatedCostsNetOfTax
-900000 USD
CY2020Q2 cfx Disposal Group Including Discontinued Operations Asbestos Related Costs Net Of Tax
DisposalGroupIncludingDiscontinuedOperationsAsbestosRelatedCostsNetOfTax
-1400000 USD
CY2021Q2 us-gaap Cash Provided By Used In Operating Activities Discontinued Operations
CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
-7300000 USD
CY2021Q2 cfx Numberof Sales Channels
NumberofSalesChannels
3 salesChannel
CY2020Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
36600000 USD
CY2019Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
14800000 USD
CY2020Q2 us-gaap Cash Provided By Used In Operating Activities Discontinued Operations
CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
-800000 USD
CY2021Q2 cfx Business Combination Intangible Assets Acquired Percentages Of Consideration Paid
BusinessCombinationIntangibleAssetsAcquiredPercentagesOfConsiderationPaid
0.46
CY2021Q2 cfx Business Acquisition Proforma Revenue Percentage Of Company Consolidated Revenue
BusinessAcquisitionProformaRevenuePercentageOfCompanyConsolidatedRevenue
0.01
CY2021Q2 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
14300000 USD
CY2020Q2 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
4900000 USD
CY2021Q2 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
40000000.0 USD
CY2020Q2 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
17000000.0 USD
CY2021Q2 cfx Contractwith Customer Liability One Time Advance Payments
ContractwithCustomerLiabilityOneTimeAdvancePayments
11800000 USD
CY2021Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
35600000 USD
CY2020Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
37666000 USD
CY2021Q2 us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
239000 USD
CY2021Q2 us-gaap Financing Receivable Allowance For Credit Losses Write Offs
FinancingReceivableAllowanceForCreditLossesWriteOffs
1062000 USD
CY2021Q2 cfx Financing Receivable Allowancefor Credit Loss Foreign Currency Translation1
FinancingReceivableAllowanceforCreditLossForeignCurrencyTranslation1
-1283000 USD
CY2021Q2 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
35560000 USD
CY2021Q2 cfx Net Incomefromcontinuingoperationsattributableto Parent
NetIncomefromcontinuingoperationsattributabletoParent
26564000 USD
CY2020Q2 cfx Net Incomefromcontinuingoperationsattributableto Parent
NetIncomefromcontinuingoperationsattributabletoParent
7841000 USD
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
139603389 shares
CY2020Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
136601111 shares
CY2021Q2 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.19
CY2020Q2 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.06
CY2021Q2 cfx Net Incomefromcontinuingoperationsattributableto Parent
NetIncomefromcontinuingoperationsattributabletoParent
26564000 USD
CY2021Q2 cfx Weighted Average Number Of Shares Outstanding Tangible Equity Units Diluted
WeightedAverageNumberOfSharesOutstandingTangibleEquityUnitsDiluted
3700000 shares
CY2020Q2 cfx Net Incomefromcontinuingoperationsattributableto Parent
NetIncomefromcontinuingoperationsattributabletoParent
7841000 USD
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
139603389 shares
CY2020Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
136601111 shares
CY2021Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
2167918 shares
CY2020Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
4868927 shares
CY2021Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
141771307 shares
CY2020Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
141470038 shares
CY2021Q2 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0.19
CY2020Q2 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0.06
CY2021Q2 us-gaap Income Loss From Continuing Operations Attributable To Noncontrolling Entity
IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity
1200000 USD
CY2020Q2 us-gaap Income Loss From Continuing Operations Attributable To Noncontrolling Entity
IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity
1000000.0 USD
CY2021Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1400000 shares
CY2020Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3900000 shares
CY2021Q2 cfx Tangible Equity Unit Reference Price
TangibleEquityUnitReferencePrice
20.81
CY2021Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
7900000 USD
CY2021Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.222 Rate
CY2020Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
22000000.0 USD
CY2020Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
13200000 USD
CY2020Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.598 Rate
CY2021Q2 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
100000000 USD
CY2021Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-84155000 USD
CY2021Q2 cfx Other Comprehensive Income Loss Intra Entity Foreign Currency Translation Adjustment Adjustments Net Of Tax
OtherComprehensiveIncomeLossIntraEntityForeignCurrencyTranslationAdjustmentAdjustmentsNetOfTax
31098000 USD
CY2021Q2 us-gaap Other Comprehensive Income Loss Before Reclassifications Net Of Tax
OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
-40676000 USD
CY2021Q2 us-gaap Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax
ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
-1055000 USD
CY2021Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-39621000 USD
CY2020Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-170317000 USD
CY2020Q2 cfx Other Comprehensive Income Loss Intra Entity Foreign Currency Translation Adjustment Adjustments Net Of Tax
OtherComprehensiveIncomeLossIntraEntityForeignCurrencyTranslationAdjustmentAdjustmentsNetOfTax
-1027000 USD
CY2020Q2 us-gaap Other Comprehensive Income Loss Before Reclassifications Net Of Tax
OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
-159164000 USD
CY2020Q2 us-gaap Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax
ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
-867000 USD
CY2020Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-158297000 USD
CY2019Q1 cfx Tangible Equity Units Issued Amount
TangibleEquityUnitsIssuedAmount
4600000 USD
CY2019Q1 cfx Tangible Equity Units Issued Par Value
TangibleEquityUnitsIssuedParValue
100
CY2019Q1 cfx Tangible Equity Units Issued Cash Proceeds
TangibleEquityUnitsIssuedCashProceeds
447700000 USD
CY2021Q2 cfx Tangible Equity Unit Threshold Appreciation Price
TangibleEquityUnitThresholdAppreciationPrice
25.00
CY2021Q2 cfx Tangible Equity Unit Reference Price
TangibleEquityUnitReferencePrice
20.81
CY2021Q2 cfx Tangible Equity Unit Threshold Appreciation Price
TangibleEquityUnitThresholdAppreciationPrice
25.00
CY2019Q1 cfx Tangible Equity Units Issued Par Value
TangibleEquityUnitsIssuedParValue
100
CY2021Q2 cfx Stock Purchase Contracts Converted
StockPurchaseContractsConverted
100000 shares
CY2021Q2 us-gaap Inventory Raw Materials
InventoryRawMaterials
116562000 USD
CY2020Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
110848000 USD
CY2021Q2 us-gaap Inventory Work In Process
InventoryWorkInProcess
44613000 USD
CY2020Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
40517000 USD
CY2021Q2 us-gaap Inventory Finished Goods
InventoryFinishedGoods
504806000 USD
CY2020Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
476297000 USD
CY2021Q2 us-gaap Inventory Gross
InventoryGross
665981000 USD
CY2020Q4 us-gaap Inventory Gross
InventoryGross
627662000 USD
CY2021Q2 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
59773000 USD
CY2020Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
62840000 USD
CY2021Q2 us-gaap Inventory Net
InventoryNet
606208000 USD
CY2020Q4 us-gaap Inventory Net
InventoryNet
564822000 USD
CY2021Q2 us-gaap Long Term Debt
LongTermDebt
2209366000 USD
CY2020Q4 us-gaap Long Term Debt
LongTermDebt
2231243000 USD
CY2021Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
727369000 USD
CY2020Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
27074000 USD
CY2021Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1481997000 USD
CY2020Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
2204169000 USD
CY2021Q2 us-gaap Debt Weighted Average Interest Rate
DebtWeightedAverageInterestRate
0.0186
CY2021Q2 us-gaap Line Of Credit Facility Remaining Borrowing Capacity
LineOfCreditFacilityRemainingBorrowingCapacity
975000000 USD
CY2021Q2 cfx Tangible Equity Unit Initial Principal Amount
TangibleEquityUnitInitialPrincipalAmount
15.6099
CY2021Q2 cfx Interest Rateof Tangible Equity Notes
InterestRateofTangibleEquityNotes
0.0650
CY2021Q2 cfx Tangible Equity Unit Quarterly Cash Distribution
TangibleEquityUnitQuarterlyCashDistribution
1.4375
CY2021Q2 cfx Tangible Equity Unit Repayment
TangibleEquityUnitRepayment
6600000 USD
CY2021Q2 cfx Letters Of Credit Maximum Capacity
LettersOfCreditMaximumCapacity
338600000 USD
CY2021Q2 us-gaap Letters Of Credit Outstanding Amount
LettersOfCreditOutstandingAmount
64900000 USD
CY2021Q2 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
21000000.0 USD
CY2021Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
85509000 USD
CY2020Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
98455000 USD
CY2021Q2 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
52031000 USD
CY2020Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
57286000 USD
CY2021Q2 cfx Accrued Asbestos Liability
AccruedAsbestosLiability
42411000 USD
CY2020Q4 cfx Accrued Asbestos Liability
AccruedAsbestosLiability
41626000 USD
CY2021Q2 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
15799000 USD
CY2020Q4 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
15543000 USD
CY2021Q2 us-gaap Restructuring Reserve Current
RestructuringReserveCurrent
7385000 USD
CY2020Q4 us-gaap Restructuring Reserve Current
RestructuringReserveCurrent
7889000 USD
CY2021Q2 us-gaap Accrued Sales Commission Current
AccruedSalesCommissionCurrent
26990000 USD
CY2020Q4 us-gaap Accrued Sales Commission Current
AccruedSalesCommissionCurrent
25480000 USD
CY2021Q2 cfx Customeradvancesandbillinginexcessofcostsincurred
Customeradvancesandbillinginexcessofcostsincurred
40051000 USD
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
454333000 USD
CY2020Q4 cfx Customeradvancesandbillinginexcessofcostsincurred
Customeradvancesandbillinginexcessofcostsincurred
36737000 USD
CY2021Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
37791000 USD
CY2020Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
39695000 USD
CY2021Q2 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
14653000 USD
CY2020Q4 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
27153000 USD
CY2021Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
101678000 USD
CY2020Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
104469000 USD
CY2021Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
424298000 USD
CY2020Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
15543000 USD
CY2019Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
15528000 USD
CY2021Q2 us-gaap Product Warranty Accrual Warranties Issued
ProductWarrantyAccrualWarrantiesIssued
2042000 USD
CY2020Q2 us-gaap Product Warranty Accrual Warranties Issued
ProductWarrantyAccrualWarrantiesIssued
1121000 USD
CY2021Q2 us-gaap Product Warranty Accrual Preexisting Increase Decrease
ProductWarrantyAccrualPreexistingIncreaseDecrease
589000 USD
CY2020Q2 us-gaap Product Warranty Accrual Preexisting Increase Decrease
ProductWarrantyAccrualPreexistingIncreaseDecrease
318000 USD
CY2021Q2 us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
2472000 USD
CY2020Q2 us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
1910000 USD
CY2021Q2 us-gaap Product Warranty Accrual Additions From Business Acquisition
ProductWarrantyAccrualAdditionsFromBusinessAcquisition
321000 USD
CY2020Q2 us-gaap Product Warranty Accrual Additions From Business Acquisition
ProductWarrantyAccrualAdditionsFromBusinessAcquisition
0 USD
CY2021Q2 us-gaap Standard And Extended Product Warranty Accrual Foreign Currency Translation Gain Loss
StandardAndExtendedProductWarrantyAccrualForeignCurrencyTranslationGainLoss
-224000 USD
CY2020Q2 us-gaap Standard And Extended Product Warranty Accrual Foreign Currency Translation Gain Loss
StandardAndExtendedProductWarrantyAccrualForeignCurrencyTranslationGainLoss
-1309000 USD
CY2021Q2 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
15799000 USD
CY2020Q2 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
13748000 USD
CY2020Q4 us-gaap Restructuring Reserve
RestructuringReserve
8108000 USD
CY2021Q2 cfx Restructuring Settlementand Impairment Provisionsbeforenoncashcharges
RestructuringSettlementandImpairmentProvisionsbeforenoncashcharges
4046000 USD
CY2021Q2 us-gaap Payments For Restructuring
PaymentsForRestructuring
4739000 USD
CY2021Q2 us-gaap Restructuring Reserve Translation Adjustment
RestructuringReserveTranslationAdjustment
-17000 USD
CY2021Q2 us-gaap Restructuring Reserve
RestructuringReserve
7398000 USD
CY2021Q2 cfx Noncashimpairmentrestructuringprovisions
Noncashimpairmentrestructuringprovisions
0 USD
CY2021Q2 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
19635000 USD
CY2021Q2 us-gaap Deferred Compensation Liability Current And Noncurrent
DeferredCompensationLiabilityCurrentAndNoncurrent
11802000 USD
CY2021Q2 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
15993000 USD
CY2020Q2 us-gaap Deferred Compensation Plan Assets
DeferredCompensationPlanAssets
10881000 USD
CY2020Q2 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
20495000 USD
CY2020Q2 us-gaap Deferred Compensation Liability Current And Noncurrent
DeferredCompensationLiabilityCurrentAndNoncurrent
10881000 USD
CY2021Q2 us-gaap Restructuring Settlement And Impairment Provisions
RestructuringSettlementAndImpairmentProvisions
4046000 USD
CY2020Q4 us-gaap Long Term Debt Fair Value
LongTermDebtFairValue
2300000000 USD
CY2021Q2 us-gaap Long Term Debt Fair Value
LongTermDebtFairValue
2300000000 USD
CY2021Q2 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
6252000 USD
CY2021Q2 us-gaap Deferred Compensation Plan Assets
DeferredCompensationPlanAssets
11802000 USD
CY2020Q2 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
7420000 USD
CY2020Q2 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
12662000 USD
CY2021Q2 us-gaap Derivative Asset Notional Amount
DerivativeAssetNotionalAmount
309400000 USD
CY2020Q4 us-gaap Derivative Asset Notional Amount
DerivativeAssetNotionalAmount
250400000 USD
CY2021Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
763653000 USD
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
97068000 USD
CY2021Q2 us-gaap Restricted Cash
RestrictedCash
0 USD
CY2020Q4 us-gaap Restricted Cash
RestrictedCash
4001000 USD
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
763653000 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
101069000 USD
CY2020Q4 us-gaap Loss Contingency Pending Claims Number
LossContingencyPendingClaimsNumber
14809
CY2019Q4 us-gaap Loss Contingency Pending Claims Number
LossContingencyPendingClaimsNumber
16299
CY2021Q2 us-gaap Loss Contingency New Claims Filed Number
LossContingencyNewClaimsFiledNumber
1067
CY2020Q2 us-gaap Loss Contingency New Claims Filed Number
LossContingencyNewClaimsFiledNumber
1043
CY2021Q2 us-gaap Loss Contingency Claims Settled And Dismissed Number
LossContingencyClaimsSettledAndDismissedNumber
581
CY2020Q2 us-gaap Loss Contingency Claims Settled And Dismissed Number
LossContingencyClaimsSettledAndDismissedNumber
600
CY2021Q2 us-gaap Loss Contingency Pending Claims Number
LossContingencyPendingClaimsNumber
15295
CY2020Q2 us-gaap Loss Contingency Pending Claims Number
LossContingencyPendingClaimsNumber
16742
CY2021Q2 cfx Asbestos Insurance Asset Noncurrent
AsbestosInsuranceAssetNoncurrent
229879000 USD
CY2021Q2 us-gaap Revenues
Revenues
879211000 USD
CY2020Q4 cfx Asbestos Insurance Asset Noncurrent
AsbestosInsuranceAssetNoncurrent
232712000 USD
CY2021Q2 cfx Insurance Receivable Asbestos Noncurrent
InsuranceReceivableAsbestosNoncurrent
27868000 USD
CY2020Q4 cfx Insurance Receivable Asbestos Noncurrent
InsuranceReceivableAsbestosNoncurrent
31815000 USD
CY2021Q2 cfx Accrued Asbestos Liability
AccruedAsbestosLiability
42411000 USD
CY2020Q4 cfx Accrued Asbestos Liability
AccruedAsbestosLiability
41626000 USD
CY2021Q2 cfx Asbestos Liability Noncurrent
AsbestosLiabilityNoncurrent
248669000 USD
CY2020Q4 cfx Asbestos Liability Noncurrent
AsbestosLiabilityNoncurrent
253144000 USD
CY2021Q2 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
2 segment
CY2020Q2 us-gaap Revenues
Revenues
816356000 USD
CY2021Q2 cfx Segment Operating Income
SegmentOperatingIncome
67106000 USD
CY2020Q2 cfx Segment Operating Income
SegmentOperatingIncome
58762000 USD
CY2021Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
35647000 USD
CY2020Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
22041000 USD
CY2021Q2 us-gaap Interest Expense
InterestExpense
25660000 USD
CY2020Q2 us-gaap Interest Expense
InterestExpense
24796000 USD
CY2021Q2 cfx Restructuring Chargesand Other Related Charges
RestructuringChargesandOtherRelatedCharges
4046000 USD
CY2020Q2 cfx Restructuring Chargesand Other Related Charges
RestructuringChargesandOtherRelatedCharges
11025000 USD
CY2021Q2 cfx Medical Device Regulation Costs
MedicalDeviceRegulationCosts
1753000 USD
CY2020Q2 cfx Medical Device Regulation Costs
MedicalDeviceRegulationCosts
900000 USD
CY2021Q2 cfx Segment Operating Income
SegmentOperatingIncome
67106000 USD
CY2020Q2 cfx Segment Operating Income
SegmentOperatingIncome
58762000 USD
CY2021Q2 dei Document Period End Date
DocumentPeriodEndDate
2021-04-02

Files In Submission

Name View Source Status
0001420800-21-000016-index-headers.html Edgar Link pending
0001420800-21-000016-index.html Edgar Link pending
0001420800-21-000016.txt Edgar Link pending
0001420800-21-000016-xbrl.zip Edgar Link pending
cfx-20210402.htm Edgar Link pending
cfx-20210402.xsd Edgar Link pending
cfx-20210402_cal.xml Edgar Link unprocessable
cfx-20210402_def.xml Edgar Link unprocessable
cfx-20210402_htm.xml Edgar Link completed
cfx-20210402_lab.xml Edgar Link unprocessable
cfx-20210402_pre.xml Edgar Link unprocessable
exhibit3101ceocertificatio.htm Edgar Link pending
exhibit3102cfocertificatio.htm Edgar Link pending
exhibit3201ceocertificatio.htm Edgar Link pending
exhibit3202cfocertificatio.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending